Viferon, 40000 me/g ointment 12 g

Immunomodulatory and antiviral drug. Interferon human recombinant alpha-2 has pronounced antiviral, antiproliferative and immunomodulatory properties.

In the presence of additives of the preparation (antioxidant tocopherol acetate) the specific antiviral activity of human recombinant interferon alpha-2 increases and its immunomodulatory activity increases (stimulation of phagocytic function of neutrophils in lesions).

In external and local administration the systemic absorption of interferon is low.

Indications

As part of complex therapy for influenza and other acute respiratory viral infections in children over 1 year of age.
For the treatment of herpetic infections (Herpes simplex types 1 and 2) of the skin and mucous membranes of various locations.

Pharmacological effect

Pharmacotherapeutic group Cytokine.

ATX code L03АВ05

Pharmacological properties
Immunomodulatory and antiviral drug. Human recombinant interferon alpha-2b has pronounced antiviral, antiproliferative and immunomodulatory properties. In the presence of excipients included in the drug, the specific antiviral activity of human recombinant interferon alpha-2b increases and its immunomodulatory effect (stimulation of the phagocytic function of neutrophils in lesions) increases.
When applied externally and locally, systemic absorption of interferon is low.

Special instructions

Impact on the ability to drive vehicles and engage in other activities
Not installed.

Active ingredient

Interferon alpha-2b

Composition

Composition per 1 g of ointment:
Active ingredient: interferon alpha-2b 40,000 IU;
Excipients: alpha-tocopherol acetate, lanolin anhydrous, petrolatum, peach oil, calcium pantothenate, sodium benzoate, human albumin, sodium acetate trihydrate, sodium chloride, disodium edetate dihydrate, purified water.

Pregnancy

Since the systemic absorption of interferon when applied externally and locally is low and the drug has an effect only in the affected area, it is possible to use the drug VIFERON®, ointment, during pregnancy and during breastfeeding.

Contraindications

Individual intolerance to the components of the drug.
Children under 1 year of age.

Side Effects

In most cases, VIFERON®, an ointment for external and local use, is well tolerated. When applied to the nasal mucosa, side effects (rhinorrhea, sneezing, burning of the nasal mucosa) are mild and transient and disappear on their own after discontinuation of the drug.

Interaction

Not detected.

Overdose

Not installed.

Storage conditions

At temperatures from 2 to 8 C.
Keep out of the reach of children.

Shelf life

2 years.
Do not use the drug after the expiration date.

Manufacturer

Feron, Russia